RECURrence of Atrial Fibrillation After Cardioversion of Patients Randomized to Dapagliflozin or Usual Care

NCT07187570 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

1600

Enrollment

OTHER_GOV

Sponsor class

Conditions

Atrial Fibrillation (AF)

Interventions

DRUG: Dapagliflozin 10 mg once daily

Sponsor

Region Stockholm

Collaborators

[object Object]